Magnus Financial Group’s Generate Biomedicines GENB Stock Holding History
Bought
Maintained
Sold
Other funds holding GENB
Magnus Financial Group's GENB Position: Q2 2026 in Review
Magnus Financial Group opened a new position in Generate Biomedicines (GENB) in Q2 2026: 15,600 shares worth $263K. The stake represents 0.02% of the portfolio and ranks #335 among its holdings.
3 funds tracked by Wall St. Rank hold GENB as of Q2 2026.
- Magnus Financial Group held 15,600 shares of Generate Biomedicines worth $263K as of Q2 2026.
- Generate Biomedicines was a new Magnus Financial Group position in Q2 2026.
- Generate Biomedicines made up 0.02% of Magnus Financial Group's portfolio in Q2 2026, its #335 holding.
- 3 funds tracked by Wall St. Rank held Generate Biomedicines as of Q2 2026.
Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.